OUR Portfolio
Tullis Opportunity Fund

			Coherex Medical, Inc. Coherex is a medical device developer focused on addressing patent foramen ovale ("PFO") closure as its initial target. PFO is a common heart defect that occurs in approximately 20% of the population.

			ReVision Therapeutics, Inc. A spinout from Sirion Therapeutics, Inc., ReVision is an ophthalmic biopharmaceutical company developing a novel, small-molecule drug for the treatment and prevention of dry age-related macular degeneration, a $1+ billion market.

			Sirion Therapeutics, Inc. Biopharmaceutical company pursuing the discovery, development, and commercialization of products addressing unmet medical needs in the protection and preservation of eyesight. Two of Sirion's products were acquired by Alcon in March 2010; a third was acquired by Bausch & Lomb in June 2010.

			Vidacare Corporation Vidacare is the leading developer, manufacturer and marketer of advanced intraosseous access technology for multiple diagnostic, monitoring and therapeutic applications. Vidacare products are marketed in over 50 countries worldwide.